John J. Puisis
Directeur Général chez Cour Pharmaceuticals Development Co., Inc.
Profil
John J.
Puisis was the founder of Tolera Therapeutics, Inc. established in 2007, where he held the position of President, Chief Executive Officer & Director from 2010 to 2013.
Mr. Puisis is also the founder of Cour Pharmaceuticals Development Co., Inc. Mr. Puisis's former positions include President & Chief Executive Officer at Third Wave Technologies, Inc. from 2000 to 2005, Director at Sierra Oncology, Inc., and Consultant at DEKALB Genetics Corp.
Mr. Puisis's education includes an MBA from Northwestern University and an undergraduate degree from Northern Illinois University.
Postes actifs de John J. Puisis
| Sociétés | Poste | Début |
|---|---|---|
Cour Pharmaceuticals Development Co., Inc.
 Cour Pharmaceuticals Development Co., Inc. BiotechnologyHealth Technology Cour Pharmaceuticals Development Co., Inc. engages in the development of therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. Its product pipeline include celiac disease, peanut allergy, multiple sclerosis, and neutralizing antibodies. The company was founded by John J. Puisis and Jim Herrmann and is headquartered in Chicago, IL. | Directeur Général | - |
Anciens postes connus de John J. Puisis
| Sociétés | Poste | Fin |
|---|---|---|
Tolera Therapeutics, Inc.
 Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Fondateur | 03/12/2013 |
Third Wave Technologies, Inc.
 Third Wave Technologies, Inc. BiotechnologyHealth Technology Third Wave Technologies, Inc. developed DNA and RNA detection technology. It provided molecular solutions for clinical, research, and agricultural customers. The company was founded in February 1993 and was headquartered in Madison, WI. | Directeur Général | 15/12/2005 |
| SIERRA ONCOLOGY, INC. | Directeur/Membre du Conseil | - |
DEKALB Genetics Corp.
 DEKALB Genetics Corp. Agricultural Commodities/MillingProcess Industries DEKALB Genetics Corp. researches and develops hybrid agricultural products such as corn, soybeans, sorghum, alfalfa and sunflowers. The company sells Sudax brand sorghum-sudangrass and markets alfalfa and other forage mixtures. DEKALB Genetics was founded in 1917 and is headquartered in Dekalb, IL | Corporate Officer/Principal | - |
Formation de John J. Puisis
| Northern Illinois University | Undergraduate Degree |
| Northwestern University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Third Wave Technologies, Inc.
Third Wave Technologies, Inc. BiotechnologyHealth Technology Third Wave Technologies, Inc. developed DNA and RNA detection technology. It provided molecular solutions for clinical, research, and agricultural customers. The company was founded in February 1993 and was headquartered in Madison, WI. | Health Technology |
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Commercial Services |
DEKALB Genetics Corp.
DEKALB Genetics Corp. Agricultural Commodities/MillingProcess Industries DEKALB Genetics Corp. researches and develops hybrid agricultural products such as corn, soybeans, sorghum, alfalfa and sunflowers. The company sells Sudax brand sorghum-sudangrass and markets alfalfa and other forage mixtures. DEKALB Genetics was founded in 1917 and is headquartered in Dekalb, IL | Process Industries |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. BiotechnologyHealth Technology Cour Pharmaceuticals Development Co., Inc. engages in the development of therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. Its product pipeline include celiac disease, peanut allergy, multiple sclerosis, and neutralizing antibodies. The company was founded by John J. Puisis and Jim Herrmann and is headquartered in Chicago, IL. | Health Technology |